Loading company…
Olio Labs develops combination therapeutics using AI and machine learning.
Olio Labs uses AI and machine learning to develop combination therapeutics based on interactions among proteins in the body. Founded in 2023 by David Tingley and Tom Roseberry, it is based in California, US. It raised USD 4.5 million in March 2025, co-led by Boom Capital Management and Overwater Ventures, with participation from Pioneer Fund, SciFounders, Scrum Ventures, Y Combinator, and ZAKA.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in